Top

HLS Therapeutics Inc.

TSX Exchange | Dec 9, 2019, 1:21 PM EST | Real-time price

HLS $ 17.61 RT
CHANGE
0.37 (2.1462%)
VOLUME
24,022
Day Low: 17.18
Day High: 17.94
Detailed Quote
Open: 17.73
High: 17.94
Beta: -1.6869
Listed Shares Out.1: 30,742,253
Total Shares (All Classes)2: 30,741,246
Prev. Close: 17.24
Low: 17.18
VWAP: 17.566
Market Cap1: 541,371,075
Market Cap (All Classes)2*: 541,353,342
Dividend: 0.05 CAD
Div. Frequency: Quarterly
P/E Ratio: N/A
EPS: -0.38
Yield: 1.16
Ex-Div Date: 01/30/2020
P/B Ratio: 2.177
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company earns most of its revenue from the United States. More

News Headlines for HLS Therapeutics Inc.
HLS Therapeutics Announces Q3 2019 Financial Results

Canada Newswire , 6:30 AM EST November 07, 2019

HLS Therapeutics to Host Q3 2019 Financial Results Conference Call

Canada Newswire , 6:30 AM EDT October 24, 2019

Research
News Headlines for HLS Therapeutics Inc.
HLS Therapeutics Announces Q3 2019 Financial Results

Canada Newswire , 6:30 AM EST November 07, 2019

HLS Therapeutics to Host Q3 2019 Financial Results Conference Call

Canada Newswire , 6:30 AM EDT October 24, 2019

Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.